title: Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
abstract: Colon cancer is the second most lethal cancer and is predicted to claim 49,700 lives in the United States this year. Chromosome instability (CIN) is observed in 80% to 90% of colon cancers and is thought to contribute to colon cancer progression and recurrence. To investigate the impact of CIN on colon cancer development, we developed shugoshin-1 (Sgo1) haploinsufficient (-/+) mice, an animal model focusing on mitotic error-induced CIN. In this study, we analyzed signature changes in the colonic transcriptome of Sgo1(-/+) mice to examine the molecular events underlying the altered carcinogenesis profiles in Sgo1(-/+) mice. We performed next-generation sequencing of normal-looking colonic mucosal tissue from mice treated with the carcinogen azoxymethane after 24 weeks. Transcriptome profiling revealed 349 hits with a 2-fold expression difference threshold (217 upregulated genes, 132 downregulated genes, P < 0.05). Pathway analyses indicated that the Sgo1-CIN tissues upregulated pathways known to be activated in colon cancer, including lipid metabolism (z score 4.47), Notch signaling (4.47), insulin signaling (3.81), and PPAR pathways (3.75), and downregulated pathways involved in immune responses including allograft rejection (6.69) and graft-versus-host disease (6.54). Notably, stem cell markers were also misregulated. Collectively, our findings demonstrate that systemic CIN results in transcriptomic changes in metabolism, proliferation, cell fate, and immune responses in the colon, which may foster a microenvironment amenable to cancer development. Therefore, therapeutic approaches focusing on these identified pathways may be valuable for colon cancer prevention and treatment.
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Chinthalapally V
authors.initials: CV
authors.lastname: Rao
authors.affiliation: College of Arts & Sciences, Baylor University, Waco, Texas.
authors.forename: Saira
authors.initials: S
authors.lastname: Sanghera
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Yuting
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Laura
authors.initials: L
authors.lastname: Biddick
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Arun
authors.initials: A
authors.lastname: Reddy
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Stan
authors.initials: S
authors.lastname: Lightfoot
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Naveena B
authors.initials: NB
authors.lastname: Janakiram
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors.forename: Altaf
authors.initials: A
authors.lastname: Mohammed
authors.affiliation: Department of Environmental Medicine, New York University Langone Medical Center, Tuxedo, New York.
authors.forename: Wei
authors.initials: W
authors.lastname: Dai
authors.affiliation: Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Hiroshi-yamada@ouhsc.edu.
authors.forename: Hiroshi Y
authors.initials: HY
authors.lastname: Yamada
mesh_terms: D000818:Animals; D043171:Chromosomal Instability; D003110:Colonic Neoplasms / Q000235:genetics* / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic
references.citation: Am J Clin Nutr. 2007 Sep;86(3):s858-66
references.pmid: 18265479
references.citation: Trends Cell Biol. 2012 May;22(5):257-65
references.pmid: 22397947
references.citation: Proc Natl Acad Sci U S A. 2007 May 22;104(21):8995-9000
references.pmid: 17517657
references.citation: J Mol Biol. 2006 May 26;359(1):22-34
references.pmid: 16616934
references.citation: Nat Genet. 2006 Sep;38(9):1043-8
references.pmid: 16921376
references.citation: Curr Biol. 2014 Feb 17;24(4):R148-9
references.pmid: 24556433
references.citation: Endocrinology. 2007 Apr;148(4):1539-49
references.pmid: 17204560
references.citation: Genes Dev. 2012 Dec 15;26(24):2696-708
references.pmid: 23222101
references.citation: Carcinogenesis. 2012 Feb;33(2):466-72
references.pmid: 22159224
references.citation: Int J Cancer. 2015 Sep 1;137(5):1224-34
references.pmid: 25683336
references.citation: Oncogene. 2015 Jul 30;34(31):4044-55
references.pmid: 25347746
references.citation: Carcinogenesis. 2009 Sep;30(9):1469-74
references.pmid: 19372138
references.citation: Cancer Metastasis Rev. 2013 Dec;32(3-4):391-402
references.pmid: 23595307
references.citation: Genes Chromosomes Cancer. 2007 Jan;46(1):10-26
references.pmid: 17044061
references.citation: Cell Stem Cell. 2012 Oct 5;11(4):461-9
references.pmid: 23040475
references.citation: J Natl Cancer Inst. 2014 Apr;106(4):dju052
references.pmid: 24681603
references.citation: Front Oncol. 2013 May 21;3:130
references.pmid: 23734346
references.citation: Oncogene. 2008 May 29;27(24):3457-64
references.pmid: 18193091
references.citation: Mol Cancer Res. 2004 Mar;2(3):159-69
references.pmid: 15037655
references.citation: Nat Rev Cancer. 2011 May;11(5):338-51
references.pmid: 21508972
references.citation: Cell. 2015 Jun 18;161(7):1539-52
references.pmid: 26091037
references.citation: Oncogene. 2002 May 9;21(20):3253-7
references.pmid: 12082642
references.citation: Immunol Lett. 2014 Sep;161(1):140-8
references.pmid: 24956310
references.citation: Neoplasia. 2012 Dec;14(12):1249-59
references.pmid: 23308056
references.citation: Mol Carcinog. 2016 May;55(5):600-10
references.pmid: 25773652
references.citation: J Biol Chem. 2008 Feb 1;283(5):2793-803
references.pmid: 18032378
references.citation: Nat Rev Cancer. 2010 Feb;10(2):102-15
references.pmid: 20094045
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Carcinogenesis. 2015 Apr;36(4):429-40
references.pmid: 25740822
references.citation: Oncotarget. 2010 Oct;1(6):387-95
references.pmid: 21311095
references.citation: Adv Exp Med Biol. 2014;816:25-52
references.pmid: 24818718
references.citation: Trends Genet. 2008 Sep;24(9):457-66
references.pmid: 18675487
references.citation: Int J Cancer. 2014 Sep 1;135(5):1048-59
references.pmid: 24500912
references.citation: Oncogene. 2013 Oct;32(40):4727-36
references.pmid: 23318433
references.citation: Genes Dev. 2004 Jun 15;18(12):1385-90
references.pmid: 15198980
references.citation: Science. 2008 Oct 31;322(5902):703-9
references.pmid: 18974345
references.citation: Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1171-7
references.pmid: 15315910
references.citation: Biochim Biophys Acta. 2008 Sep;1786(1):73-82
references.pmid: 18706976
references.citation: Gut. 2009 Feb;58(2):249-60
references.pmid: 18635744
references.citation: Oncogene. 2011 Nov 3;30(44):4453-63
references.pmid: 21532624
references.citation: J Lipid Res. 2010 May;51(5):975-82
references.pmid: 19797618
references.citation: Annu Rev Nutr. 2014;34:281-303
references.pmid: 24850384
references.citation: Cell Cycle. 2012 Feb 1;11(3):479-88
references.pmid: 22262168
references.citation: Cancer Cell. 2007 Jan;11(1):25-36
references.pmid: 17189716
references.citation: Physiol Rev. 2012 Jul;92(3):1061-85
references.pmid: 22811425
references.citation: Cell Cycle. 2013 Feb 1;12(3):473-9
references.pmid: 23324343
references.citation: Cancer Res. 2010 Feb 15;70(4):1469-78
references.pmid: 20145124
references.citation: Mol Oncol. 2010 Oct;4(5):373-84
references.pmid: 20598659
references.citation: Biochim Biophys Acta. 2009 Jun;1791(6):419-40
references.pmid: 19375517
references.citation: Nature. 2010 Mar 18;464(7287):436-40
references.pmid: 20173739
references.citation: J Mol Med (Berl). 2014 Aug;92(8):811-23
references.pmid: 24996520